首页> 外文期刊>Alternatives to laboratory animals: ATLA >Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods.
【24h】

Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods.

机译:ECVAM国际体外胚胎毒性测试验证研究的测试化学品的选择。欧洲替代方法验证中心。

获取原文
获取原文并翻译 | 示例
       

摘要

The European Centre for the Validation of Alternative Methods (ECVAM) has sponsored a large international prevalidation and validation study of three embryotoxicity tests, involving embryonic stem cells, limb bud micromass cultures, and post-implantation whole-embryo cultures. The main objective of the study was to assess the performance of these in vitro tests in discriminating between non-embryotoxic, weakly embryotoxic and strongly embryotoxic compounds. An initial part of the study was to select 20 test substances for the formal validation trial, conducted under blind conditions. A database of in vivo and in vitro developmental toxicity test results was complied on 310 chemicals that had been used in previous validation studies, or suggested for such use, or that had good quality "segment II"-type in vivo data, or for which there were human data. From this database, a shortlist of about 30 candidates was constructed. Because the ECVAM study would not include metabolic activation, chemicals known to require activation for their developmental effects were excluded as candidates, although some known stable metabolites were included. Attempts were made: to include substances of diverse mechanism; to avoid overemphasis on pharmaceuticals; to avoid biologically inert substances as non-embryotoxicants; and to make the list different from those used previously. The candidates were of three categories: Class 3, strongly embryotoxic, was defined as developmentally toxic in all species tested, inducing multiple developmental effects, and with a high A/D ratio. Class 1, non-embryotoxic, was defined as not developmentally toxic at maternally toxic exposures, but which may show some minor embryo/fetal toxicity, which cannot be separated from maternal toxicity. Class 2, weakly embryotoxic, were chemicals of intermediate activity. From this candidate list, chemicals of known receptor (androgen, oestrogen, glucocorticoid, aryl hydrocarbon) mechanisms were excluded, on the basis that simple tests for such activity are already available. In addition, chemicals not freely available were excluded, and an emphasis on human data was applied. The final list of 20 chemicals was: Class 3--6-aminonicotinamide, 5-bromo- 2'-deoxyuridine, hydroxyurea, methylmercury chloride, methotrexate, all-trans-retinoic acid; Class 2--boric acid, dimethadione, lithium chloride, methoxyacetic acid, valproic acid (VPA), 2-propyl-4-pentynoic acid (4-yn-VPA), salicylic acid sodium sa and Class 1--acrylamide, D-(+)-camphor, dimethyl phthalate, diphenhydramine hydrochloride, 2-ethyl-4- methylpentanoic acid (isobutyl-ethyl-VPA), Penicillin G sodium salt, saccharin sodium hydrate.
机译:欧洲替代方法验证中心(ECVAM)赞助了一项大型国际预验证和验证研究,涉及三项胚胎毒性测试,涉及胚胎干细胞,肢芽微团培养物和植入后全胚培养物。该研究的主要目的是评估这些体外试验在区分非胚毒性,弱胚胎毒性和强胚胎毒性化合物方面的性能。研究的最初部分是选择20种测试物质用于在盲条件下进行的正式验证试验。体内和体外发育毒性测试结果的数据库基于先前验证研究中已使用或建议用于此类用途或具有良好“ segment II”型体内数据的310种化学品,或有人类数据。从该数据库中,构建了大约30个候选人的候选清单。因为ECVAM研究不包括代谢激活,所以将已知需要激活其发育作用的化学物质排除在外,尽管其中包括一些已知的稳定代谢产物。进行了尝试:包括各种机制的物质;避免过分强调药品;避免生物惰性物质作为非胚芽毒性物质;并使列表与以前使用的列表不同。候选者分为三类:3类,具有强烈的胚胎毒性,被定义为在所有测试物种中具有发育毒性,诱导多种发育效应,并且具有较高的A / D比。第1类,非胚胎毒性,定义为在母体毒性暴露下没有发育毒性,但可能显示出轻微的胚胎/胎儿毒性,无法与母体毒性分开。第2类,具有弱胚胎毒性,是中等活性的化学品。从该候选列表中,排除了已知受体机制(雄激素,雌激素,糖皮质激素,芳基烃)的化学物质,因为已经可以进行这种活性的简单测试。此外,排除了无法免费获得的化学品,并强调了人类数据。 20种化学药品的最终清单为:3--6-氨基烟酰胺,5-溴-2'-脱氧尿苷,羟基脲,氯化甲基汞,甲氨蝶呤,全反式维甲酸; 2-硼酸,二甲二酮,氯化锂,甲氧基乙酸,丙戊酸(VPA),2-丙基-4-戊酸(4-yn-VPA),水杨酸钠盐;和1类-丙烯酰胺,D-(+)-樟脑,邻苯二甲酸二甲酯,盐酸苯海拉明,2-乙基-4-甲基戊酸(异丁基-乙基-VPA),青霉素G钠盐,糖精钠水合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号